Analytical Data
-
Gene name
APITD1
- Application
-
Alternative Names
APITD1; Apoptosis-inducing TAF9-like domain-containing Protein 1
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8N2Z9
-
Expression Region
1-138aa
-
AA Sequence
MEEEAETEEQ QRFSYQQRLK AAVHYTVGCL CEEVALDKEM QFSKQTIAAI SELTFRQCEN FAKDLEMFAR HAKRTTINTE DVKLLARRSN SLLKYITDKS EEIAQINLER KAQKKKKSED GSKNSRQPAE AGVVESEN
-
Molecular Weight
15.8 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
APITD1, or APIT domain-containing protein 1, has garnered attention in recent years due to its potential role in various cellular processes and its implications in human health. Initially identified through genomic sequencing and bioinformatics approaches, APITD1 is believed to be involved in cellular signaling pathways, particularly those related to immune responses and cell proliferation. Emerging studies have suggested that alterations in APITD1 expression may be linked to several diseases, including certain cancers and autoimmune disorders. Researchers are particularly interested in creating recombinant APITD1 proteins to elucidate its biological functions and interaction mechanisms at the molecular level. The recombinant expression of APITD1 allows for an in-depth investigation into its structure-function relationships and provides a valuable tool for functional assays. Moreover, understanding the role of APITD1 could unveil novel therapeutic targets and strategies in disease management. As studies progress, the characterization of the recombinant APITD1 protein may contribute significantly to the broader fields of immunology and oncology, making it a focus for ongoing and future research endeavors.
